dacarbazine has been researched along with Carcinoma 256, Walker in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farquhar, D; Gerulath, AH; Housholder, GE; Loo, TL; Saunders, PH | 1 |
| Dean, SW; Gibson, NW; Tew, KD | 1 |
2 other study(ies) available for dacarbazine and Carcinoma 256, Walker
| Article | Year |
|---|---|
Mechanism of action and pharmacology studies with DTIC (NSC-45388).
Topics: Animals; Carcinoma 256, Walker; Dacarbazine; DNA, Neoplasm; Dogs; Humans; Leukemia L1210; Light; Mice; Microsomes, Liver; Rats; RNA, Neoplasm; Triazenes; Triazines | 1976 |
Selection of nitrogen mustard resistance in a rat tumor cell line results in loss of guanine-O6-alkyl transferase activity.
Topics: Animals; Carcinoma 256, Walker; Cell Line; Dacarbazine; DNA, Neoplasm; Drug Resistance; Mammary Neoplasms, Experimental; Mechlorethamine; Methyltransferases; O(6)-Methylguanine-DNA Methyltransferase; Rats | 1986 |